# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Factor I Deficiency

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 22 results.
Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency
Status: Not yet recruiting
Last Changed: Jun 17, 2020
First Received: Jan 04, 2019
Disease(s): Congenital Fibrinogen Deficiency
Intervention(s): Fibryga
Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency
Status: Completed
Last Changed: Jun 11, 2020
First Received: Apr 03, 2015
Disease(s): Congenital Fibrinogen Deficiency
Intervention(s): Octafibrin
Locations: St. John's Medical College Hospital, Bangalore, India
S.S Institute of Medical Science and Research Center, Davangere, India
Nemazee Hospital Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of
Hotel De Dieu de France, Beirut, Lebanon
An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency
Status: Completed
Last Changed: Jan 17, 2018
First Received: Apr 27, 2015
Disease(s): Congenital Fibrinogen Deficiency
Intervention(s): FCH
Locations: Study Site, Aurora, Colorado, United States
Study Site, Las Vegas, Nevada, United States
Study Site, Durham, North Carolina, United States
Study Site, Calgary, Alberta, Canada
Study Site, Edmonton, Alberta, Canada
... and 7 other locations.
Human Fibrinogen - Pharmacokinetics
Status: Completed
Last Changed: Sep 15, 2016
First Received: Jul 04, 2007
Disease(s): Fibrinogen Deficiency
Intervention(s): Human Fibrinogen Concentrate
Locations: Contact CSL Behring for facility details, Aurora, Colorado, United States
Contact CSL Behring for facility details, St. Petersburg, Florida, United States
Contact CSL Behring for facility details, Chicago, Illinois, United States
Contact CSL Behring for facility details, Scarborough, Maine, United States
Contact CSL Behring for facility details, New York, New York, United States
... and 11 other locations.
Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency
Status: Completed
Last Changed: Feb 12, 2016
First Received: Mar 21, 2014
Disease(s): Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital
Intervention(s): biological: human fibrinogen concentrate
Locations: Hopital Necker enfants malades, Paris, France
Hôpital Hôtel Dieu, Beirut, Lebanon
Hôpital d'enfants - CHU Avicenne, Rabat, Morocco
Faculty Ihsan Dogramaci Children's Hospital, Ankara, Turkey
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Status: Recruiting
Last Changed: Jul 25, 2019
First Received: Feb 19, 2014
Disease(s): Congenital Afibrinogenemia, Congenital Hypofibrinogenemia
Intervention(s): BT524 (fibrinogen concentrate from human plasma)
Locations: Site 11, Cairo, Egypt
Site 07, Gießen, Germany
Site 04, Avellino, Italy
Site 03, Milan, Italy
Site 05, Padua, Italy
... and 5 other locations.
Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery
Status: Completed
Last Changed: Mar 22, 2019
First Received: Oct 17, 2014
Disease(s): Congenital Fibrinogen Deficiency
Intervention(s): Octafibrin
Locations: Miami Children's Hospital, Miami, Florida, United States
Dept of Clinical Hematology for Hemorrhagic Diatheses and Anaemia, SHAT "Joan Pavel", Sofia, Bulgaria
St. John's Medical College Hospital, Bangalore, India
Sahyadri Specialty Hospital, Pune, India
Dept of Hematology, Christian Medical College, Vellore, India
... and 8 other locations.
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Status: Withdrawn
Last Changed: May 08, 2014
First Received: Jun 09, 2009
Disease(s): Afibrinogenemia, Hypofibrinogenemia, Fibrinogen Deficiency
Intervention(s): Fibrinogen Concentrate, Human (FCH), Cryoprecipitate
Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
Status: Completed
Last Changed: Mar 09, 2018
First Received: Apr 11, 2012
Disease(s): Congenital Fibrinogen Deficiency, Afibrinogenemia
Intervention(s): Octafibrin, Haemocomplettan® P or RiaSTAPTM
Locations: University of Colorado Hemophilia & Thrombosis Center, Aurora, Colorado, United States
Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
Specialized Hospital for Active Treatment "Joan Pavel", Sofia, Bulgaria
Department of Hematology St. John's Medical College Hospital, Bangalore, India
Sahyadri Speciality Hospital, Prune, India
... and 6 other locations.
Predictors of Hypofibrinogenemia in Severe Trauma
Status: Completed
Last Changed: Jul 28, 2017
First Received: Jan 13, 2017
Disease(s): Severe Trauma
Locations: HEH - Hospices Civils de Lyon, Lyon, France
CHLS, Hospices Civils de Lyon, Pierre-Bénite, France